Cleared Traditional

K091155 - ASCEND

K091155 is an FDA 510(k) clearance for ASCEND, manufactured by Neurometrix, Inc.. The device is a Class 2 Anesthesiology device with product code BXN cleared through the Traditional 510(k) pathway after a 135-day FDA review.

K091155 · Neurometrix, Inc. · Anesthesiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2009
Decision
135d
Days
Class 2
Risk

K091155 is an FDA 510(k) clearance for the ASCEND. Classified as Stimulator, Nerve, Battery-powered (product code BXN), Class II - Special Controls.

Submitted by Neurometrix, Inc. (Waltham, US). The FDA issued a Cleared decision on September 3, 2009 after a review of 135 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2775 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K091155

510(k) Number K091155 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2009
Decision Date September 03, 2009
Days to Decision 135 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
5d faster than avg
Panel avg: 140d · This submission: 135d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BXN Device Classification - Class 2, Special Controls

Product Code BXN Stimulator, Nerve, Battery-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2775
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BXN Stimulator, Nerve, Battery-powered

All 32
Devices cleared under the same product code (BXN) and FDA review panel - the closest regulatory comparables to K091155.
STIMTRODE SINGLE USE NERVE STIMULATOR
K110118 · Xavant Technology (Pty), Ltd. · Feb 2011
STIMPOD NMS450 NERVE STIMULATOR
K102084 · Xavant Technology (Pty), Ltd. · Dec 2010
STIMPOD MODEL NMS-400 NERVE STIMULATOR
K093591 · Xavant Technology (Pty), Ltd. · Dec 2009
XPOD/XMAP NERVE STIMULATOR
K072092 · Xavant Technology (Pty), Ltd. · Nov 2007
MODIFICATION TO STIMUPLEX HNS-12, MODEL 4892098
K070134 · Stockert GmbH · Mar 2007
CLAVIS
K062478 · Medtronic A/S · Feb 2007